Read the story here. Advertise at Before It's News here.
Profile image
By MarketReportsOnline
Contributor profile | More stories
Story Views
Last hour:
Last 24 hours:

Glaucoma Market 2017-2021 Global Analysis, Company Profiles, Competitive Landscape and Key Regions

% of readers think this story is Fact. Add your two cents. adds “Global Glaucoma Market: Industry Analysis & Outlook (2017-2021)” report to its research store.  

Glaucoma is a group of eye diseases which result in damage to the optic nerve and vision loss. The most common type is open-angle glaucoma with less common types including closed-angle glaucoma and normal-tension glaucoma. Open-angle glaucoma develops slowly over time and there is no pain. Side vision may begin to decrease followed by central vision resulting in blindness, if not treated. Closed-angle glaucoma can present gradually or suddenly. The sudden presentation may involve severe eye pain, blurred vision, mid-dilated pupil, redness of the eye, and nausea. Vision loss from glaucoma, once it has occurred, is permanent. Complete report available at

Though, glaucoma cannot be cured completely but the disease progression can be controlled with the help of available treatments. There are three types of modalities available for treatment of glaucoma: Drugs, Laser and Invasive Surgery. Further, based upon the approaches employed for the medication, it can be segmented into two parts: PGA Medication and Non-PGA Medication. The PGA approach reduces IOP with the help of prostaglandin (PGA). The non-PGA medication can be further divided into four sub segments: Beta blockers, Alpha blockers, Carbonic anhydrase inhibitors (CAIs) and Combination Products.

Several factors such as rising prevalence of diabetes, growing geriatric population and rising health care expenditure along with increasing disposable income and growing obese population will drive the glaucoma market growth in the next few years. Development of new drugs & devices and drug therapy focused upon IOP are the few notable market trends. However, high cost of treatment, severe side effects and hasty drug approval processes act as a major roadblock for the market growth.

The report “Global Glaucoma Market: Industry Analysis & Outlook (2017-2021)” analyzes the development of this market, with focus on the US and OUS treatment market. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players: Pfizer Inc., Novartis AG, Merck & Co., Inc. and Allergan Plc. are being profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global glaucoma market along with the study of the US market.

Purchase a copy of this “Global Glaucoma Market: Industry Analysis & Outlook (2017-2021)” research report at USD 800 (Single User License)

Key Topics Covered:

1. Overview

2. Global Glaucoma Market

3. Regional Markets

4. Market Dynamics

5. Competitive Landscape

6. Company Profiles

Major Points from List of Tables & Charts:

List of Tables:

New Glaucoma Drugs and Therapy Devices in Pipeline (2016)
Global Glaucoma Market- Key Companies Revenue & Market Cap Comparison (2016)
Major Product Developments by Pfizer Inc. (Since November 1, 2016)

List of Charts

Types of Glaucoma
Treatments Available for Glaucoma
Glaucoma Pharmaceutical Market by Segment
Global Glaucoma Market Forecast by Value (2016-2021)
Global Glaucoma Market by Segments (2016)
Global Glaucoma Drugs Market Forecast by Value (2016-2021)
Global Glaucoma Market by Drug Class (2016)
Global Glaucoma Drugs Market by Region (2016)
Global Glaucoma Patient Volume Forecast (2016-2021)
The US Glaucoma Drugs Market Forecast by Value (2016-2021)
The US Glaucoma Patient Volume Forecast (2016-2021)
The US Open Angle Glaucoma Patient Volume Forecast (2016-2021)
The US Glaucoma Prescription Volume Forecast (2016-2021)

Explore more pharmaceuticals market research as well as other newly published reports by Koncept Analytics at

About Us: 
MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Contact Us:
Ritesh Tiwari
2nd Floor, Metropole,
Next to Inox Theatre,
Bund Garden Road,
Pune – 411001.
Maharashtra, India.
Tel: + 1 888 391 5441
E-mail: [email protected]

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Please Help Support BeforeitsNews by trying our Natural Health Products below!

Order by Phone at 888-809-8385 or online at M - F 9am to 5pm EST

Order by Phone at 888-388-7003 or online at M - F 9am to 5pm EST

Order by Phone at 888-388-7003 or online at M - F 9am to 5pm EST

Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!

HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation

Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.

MitoCopper - Bioavailable Copper destroys pathogens and gives you more energy. (See Blood Video)
Oxy Powder - Natural Colon Cleanser!  Cleans out toxic buildup with oxygen! 
Nascent Iodine - Promotes detoxification, mental focus and thyroid health.
Smart Meter Cover -  Reduces Smart Meter radiation by 96%!  (See Video)

Report abuse


    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    Load more ...




    Email this story
    Email this story

    If you really want to ban this commenter, please write down the reason:

    If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.